Cittadine Andrew

Track

Insider profile

Performance

Overall performance
2.4
Performance over holding periods
2.4
30 days 90 days 120 days
Average return -11% 8.2% 15.1%
Success rate 15% 68% 82%
Transactions
12 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Cittadine Andrew's trades of Monopar Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-06-21 2024-06-20
B Purchase
72,971 +37.9%
437.74
US$1,121,646 		72,971 +37.9% 437.74 US$1,121,646
2024-06-21 2024-06-18
B Purchase
63,365 +17.9%
476.29
US$3,314,027 		63,365 +17.9% 476.29 US$3,314,027
2024-06-17 2024-06-17
B Purchase
49,769 +6.8%
238.89
US$169,499 		49,769 +6.8% 238.89 US$169,499
2024-06-17 2024-06-14
B Purchase
12,000 +9.3%
0.93
US$11,176 		12,000 +9.3% 0.93 US$11,176
2024-06-17 2024-06-13
B Purchase
12,000 +10.2%
0.91
US$10,920 		12,000 +10.2% 0.91 US$10,920
2024-06-05 2024-06-04
B Purchase
12,000 +11.4%
0.78
US$9,360 		12,000 +11.4% 0.78 US$9,360
2024-06-05 2024-06-03
B Purchase
12,000 +12.8%
0.76
US$9,120 		12,000 +12.8% 0.76 US$9,120
2024-05-31 2024-05-31
B Purchase
12,000 +14.7%
0.64
US$7,732 		12,000 +14.7% 0.64 US$7,732
2024-05-31 2024-05-30
B Purchase
12,000 +17.2%
0.64
US$7,676 		12,000 +17.2% 0.64 US$7,676
2024-05-31 2024-05-29
B Purchase
12,000 +20.8%
0.64
US$7,643 		12,000 +20.8% 0.64 US$7,643
2022-11-16 2022-11-15
B Purchase
10,000 +70.2%
3.15
US$31,500 		10,000 +70.2% 3.15 US$31,500
2022-11-16 2022-11-14
B Purchase
6,053 +74.0%
3.00
US$18,159 		6,053 +74.0% 3.00 US$18,159